Front. Endocrinol.
Frontiers in Endocrinology
Front. Endocrinol.
1664-2392
Frontiers Media S.A.
10.3389/fendo.2023.1257424
Endocrinology
Erratum
Erratum: Effect of SARS-CoV-2 BNT162b2 mRNA vaccine on thyroid autoimmunity: a twelve-month follow-up study
Frontiers Production Office
*
Frontiers Media SA, Lausanne, Switzerland
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
*Correspondence: Frontiers Production Office, production.office@frontiersin.org
24
07
2023
2023
14
1257424
12
07
2023
12
07
2023
Copyright © 2023 Frontiers Production Office
2023
Frontiers Production Office
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
An Erratum on Effect of SARS-CoV-2 BNT162b2 mRNA vaccine on thyroid autoimmunity: a twelve-month follow-up study by Morita S, Takagi T, Inaba H, Furukawa Y, Kishimoto S, Uraki S, Shimo N, Takeshima K, Uraki S, Doi K, Imagawa M, Kokawa M, Konami T, Hara H, Hara Y, Sone E, Furuta H, Nishi M, Doi A, Tamura S and Matsuoka T-a (2023) Front. Endocrinol. 14:1058007. doi: 10.3389/fendo.2023.1058007
SARS-CoV-2
COVID-19
thyroid autoimmunity
BNT162b2 vaccine
thyroid-stimulating hormone receptor antibody
Graves’ disease
section-in-acceptance
Thyroid Endocrinology
Due to a production error, an author’s name was incorrectly spelled as “Taka-aki Mastuoka”. The correct spelling is “Taka-aki Matsuoka”. The publisher apologizes for this mistake.
The original version of this article has been updated.